Stocks and Investing Stocks and Investing
Fri, March 4, 2022
[ 12:00 AM ] - WOPRAI
Greg Melich Maintained (TGT) at Hold with Increased Target to $240 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Joshua Wilson Maintained (TGLS) at Strong Buy with Decreased Target to $30 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Eric Handler Upgraded (TTWO) to Strong Buy and Held Target at $200 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
James McIlree Maintained (XXII) at Strong Buy and Held Target at $136 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Joseph Altobello Maintained (XPOF) at Strong Buy with Decreased Target to $27 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Robert Dodd Maintained (WHF) at Buy with Decreased Target to $16 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Fawne Jiang Maintained (WB) at Strong Buy with Decreased Target to $56 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Xueru Zhang Upgraded (WB) to Strong Buy and Held Target at $35 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Laura Martin Maintained (VZIO) at Strong Buy with Decreased Target to $16 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Brett Feldman Maintained (VZ) at Strong Buy and Held Target at $61 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Gabriel Moreen Maintained (WES) at Strong Buy with Increased Target to $31 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Andrew Partheniou Downgraded (VFF) to Hold on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Brad Reback Maintained (VERI) at Hold with Decreased Target to $23 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Michael Latimore Maintained (VERI) at Buy with Decreased Target to $30 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
John Franzreb Maintained (VPG) at Strong Buy with Decreased Target to $48 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Robert Burns Maintained (ADCT) at Strong Buy with Decreased Target to $54 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Jason English Downgraded (ADV) to Hold and Held Target at $7 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Tobey Sommer Maintained (APEI) at Strong Buy with Decreased Target to $26 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Mark Hughes Downgraded (AMSF) to Hold and Held Target at $50 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Patrick Colville Downgraded (AI) to Strong Sell and Decreased Target to $18 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Gary Taylor Maintained (ALHC) at Buy with Decreased Target to $11 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Fawne Jiang Maintained (BILI) at Strong Buy with Decreased Target to $75 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Steve Powers Maintained (BF) at Hold with Decreased Target to $67 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Joseph Feldman Maintained (BBY) at Buy with Increased Target to $130 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Bobby Griffin Downgraded (BBY) to Hold on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Steven Forbes Maintained (BBY) at Strong Buy with Decreased Target to $130 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Jonathan Matuszewski Maintained (BBY) at Strong B .. y with Increased Target to $140 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Scot Ciccarelli Maintained (BBY) at Hold with Increased Target to $117 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
David Long Maintained (ZION) at Strong Buy with Increased Target to $84 on, Mar 4th, 2022
[ 12:00 AM ] - WOPRAI
Keay Nakae Maintained (ABUS) at Strong Buy with Increased Target to $6 on, Mar 4th, 2022

Keay Nakae Maintained (ABUS) at Strong Buy with Increased Target to $6 on, Mar 4th, 2022


Published on 2024-10-27 19:57:47 - WOPRAI, Keay Nakae
  Print publication without navigation


Keay Nakae of Chardan Capital, Maintained "Arbutus Biopharma Corporation" (ABUS) at Strong Buy with Increased Target from $5.5 to $6 on, Mar 4th, 2022.

Keay has made no other calls on ABUS in the last 4 months.



There are 2 other peers that have a rating on ABUS. Out of the 2 peers that are also analyzing ABUS, 0 agree with Keay's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Keay

  • Dennis Ding of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $5 on, Wednesday, February 2nd, 2022
  • Jason Butler of "JMP Securities" Maintained at Buy with Increased Target to $9 on, Monday, November 8th, 2021
Contributing Sources